Molloy, in Reference Module in Biomedical Sciences, 2014 available online at sciencedirect.com/topics/bi
Northeast Florida's active outdoor culture makes this a particularly relevant audience
QD community oral or SC MOTS-c Daily SC, often 5 days on / 2 off AOD-9604 Daily SC Attribute Max studied dose SLU-PP-332 50 mg/kg BID (mouse, 28 days) MOTS-c 5-15 mg/kg (mouse) AOD-9604 1-5 mg/day in human Phase 2 Attribute Peak efficacy signal SLU-PP-332 ~25-30% fat-mass reduction in DIO mice over 28 days MOTS-c Improved insulin sensitivity in aged mice AOD-9604 Modest fat-loss signal in human Phase 2
Our commitment to purity, transparency, and traceability ensures your research outcomes are built on a foundation of trust
Treatment duration varies by indication
Some of our patients may be interested in emerging therapies like BPC-157, especially those undergoing surgeries involving the gastrointestinal tract or experiencing postoperative inflammation